australia clinical guidance

Pelvic inflammatory disease (PID)

A detailed Australian summary of pelvic inflammatory disease (pid), with source-attributed priorities, a practical workflow, safety escalation and state or territory implementation boundaries.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Apply current TGA product information, PBS restrictions, state or territory law, local referral criteria, formulary and antimicrobial policy. A national recommendation does not create uniform service access.

Scope

Maintain a low diagnostic threshold with pelvic pain plus cervical, uterine or adnexal tenderness after excluding pregnancy-related emergencies. Take pregnancy testing and appropriate chlamydia, gonorrhoea and other STI samples, but do not delay empirical treatment while awaiting results. This summary is limited to the population, decisions and escalation boundaries stated in the named source.
sources for this section:Australian STI Guidelines

The Bottom Line

  • Maintain a low diagnostic threshold with pelvic pain plus cervical, uterine or adnexal tenderness after excluding pregnancy-related emergencies.
  • Take pregnancy testing and appropriate chlamydia, gonorrhoea and other STI samples, but do not delay empirical treatment while awaiting results.
  • An intrauterine device usually does not require removal at diagnosis; review response and current Australian guidance first.
  • Use the Australian STI guideline regimen, accounting for allergy, pregnancy, severity and local resistance, and ensure the full course is completed.
sources for this section:Australian STI Guidelines

Practical clinical workflow

1

Topic-specific assessment action

Maintain a low diagnostic threshold with pelvic pain plus cervical, uterine or adnexal tenderness after excluding pregnancy-related emergencies.
2

Topic-specific diagnostic action

Use the Australian STI guideline regimen, accounting for allergy, pregnancy, severity and local resistance, and ensure the full course is completed.
3

Topic-specific management action

Arrange partner notification and treatment, abstinence advice, test follow-up and early clinical review to confirm improvement and reduce reinfection.
4

Topic-specific follow-through

Right-upper-quadrant pleuritic pain can indicate perihepatitis and supports PID even without marked pelvic findings.
sources for this section:Australian STI Guidelines

Safety boundaries and escalation

  • Hospital assessment is needed for severe illness, tubo-ovarian abscess, pregnancy, diagnostic uncertainty, inability to take oral therapy or failure to improve.
  • Offer fertility and chronic-pelvic-pain counselling after severe or recurrent disease and lower the threshold for specialist review.
sources for this section:Australian STI Guidelines

Implementation

The named source is national or binational guidance used in Australia, but referral access, public-health directions, formularies and funded services can still differ by state, territory and health service. Check current TGA product information for medicines. Offer culturally safe care and use the NACCHO鈥揜ACGP National Guide where Aboriginal and Torres Strait Islander preventive or chronic-care recommendations differ.
sources for this section:Australian STI Guidelines

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:Australian STI Guidelines

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Australasian Society for HIV, Viral Hepatitis and Sexual Health MedicineAustralian STI Management Guidelines for Use in Primary CareLiving web guideline checked 2026-08-20 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Found a source update or regional discrepancy? Tell the iatroX editorial team.